NY-ESO-1 T Cells in OG Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
GVAX vs. Placebo for MDS/AML After Allo HSCT
- Status
- TERMINATED
- Phase
- PHASE2
Assessment of Efficacy and Safety of Front-line Fludarabine, Cyclophoshamide and Ofatumumab Chemoimmunotherapy in Young Patients With Chronic Lymphocytic Leukemia.
- Status
- COMPLETED
- Phase
- PHASE2
Haploidentical Stem Cell Transplantation for Children With Acquired Severe Aplastic Anemia
- Status
- UNKNOWN
- Phase
- PHASE2
Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior Treatment
- Status
- TERMINATED
- Phase
- PHASE2
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- Status
- RECRUITING
- Phase
- NA
Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE1
CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Randomised Trial in Waldenstrom's Macroglobulinaemia
- Status
- COMPLETED
- Phase
- PHASE2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Vemurafenib and White Blood Cell Therapy for Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT)
- Status
- TERMINATED
- Phase
- PHASE2